Latest news
Publications
Read, watch, share
100 years of insulin
MSF International President appeals to governments blocking landmark COVID-19 proposal
COVID-19: No patents or profiteering in a pandemic
No monopolies - Access to COVID-19 treatment
Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action
A Snapshot of the Access Campaign
Our work
Join the conversation
Around half the people in the world do not have access to adequate diagnostic testing. @StijnDx explains how a resolution just passed at #WHA76 could change that.
19:21 - 26 May 2023
There are two new treatments for Ebola, but why are they not readily available for people most at risk? At #WHA76 this week, @JulienPotet takes us through the issues.
16:51 - 26 May 2023
Dr. Precious: We’ve once in a lifetime opportunity in form of #IHR, medical countermeasures and #PandemicAccord. Language is there that can help us in moving the access agenda forward.
16:35 - 24 May 2023
Precious Matsoso, INB Co- Chair at the Ebola : Post trial access provision is must for countries where trials take place. These countries are poor and can’t access new medical tools on their own. R&D infrastructure need to change.
15:51 - 24 May 2023
Dr Armand Sprecher, MSF : Biggest missed opportunity missed is in the Ebola therapeutics trial agreement since they didn’t mention about affordability and accessibility of therapeutics for countries in Africa where trial was done.
15:34 - 24 May 2023
